Currently, out of the existing stock ratings of Steve Byrne - 20 which are a Sell (15.5%), 65 which are a Buy (50.39%), 44 which are a Hold (34.11%)

Steve Byrne

Work Performance Price Targets & Ratings Chart

Analyst Steve Byrne works at BAML and is covering Basic Materials, Consumer Defensive, Healthcare sectors with 503 price targets and ratings displayed on 30 stocks.

Steve Byrne's average stock forecast success ratio is 71.07% with an average time for price targets to be met of 312.27 days.

Most recent stock forecast was given on MOS, The Mosaic Company at 07-Aug-2023.

Wall Street Analyst Steve Byrne

Analyst best performing recommendations are on PCRX (PACIRA BIOSCIENCES).
The best stock recommendation documented was for GPRE (GREEN PLAINS) at 10/24/2022. The price target of $35 was fulfilled within 17 days with a profit of $7.74 (28.39%) receiving and performance score of 16.7.

Average potential price target upside

of $70.92 (24.38%) on LIN (LINDE PLC).
of $40.44 (18.66%) on APD (AIR PRODUCTS AND CHEMICALS).
of $20.39 (27.54%) on BG (BUNGE).

ALB Albemarle CE Celanese CF CF Industries Holdings CTVA Corteva DD DuPont de Nemours FMC FMC HUN Huntsman LIN Linde plc LTHM Livent LYB LyondellBasell Industries N.V MOS The Mosaic Company NTR Nutrien Ltd OLN Olin RPM RPM International SHW The SherwinWilliams Company WLK APD Air Products and Chemicals BG Bunge ECL Ecolab PPG PPG Industries UNVR Univar Solutions VNTR Venator Materials PLC ADM ArcherDanielsMidland Company AXTA Axalta Coating Systems Ltd GPRE Green Plains ORGN DOW MNKD MannKind PCRX Pacira BioSciences SRPT Sarepta Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Stephen Richardson (EVERCORE)